VGAIT for Chemotherapy-induced Peripheral Neuropathy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-80
SponsorMassachusetts General Hospital
About this trial
Perform a feasibility study on imagined acupuncture treatment of Chemotherapy-induced peripheral neuropathy (CIPN)
Eligibility criteria
Qualifiers
at least 18 years of age
have histologically confirmed stage I-III breast cancer,
have completed adjuvant taxane-based chemotherapy (alone or in combination), ,
have an Eastern Cooperative Oncology Group performance status of 0 or 1, and reported grade 1 or greater CIPN symptoms for more than 2 weeks as defined by the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE), version 4.03.
Disqualifiers
concurrent chemotherapy (there were no limitations on time from the last paclitaxel administration),
having metastatic or recurrent disease,
history of preexisting peripheral neuropathy prior to chemotherapy,
uncontrolled seizure disorder,
Trial design
Treatments tested in this trial
- Video-Guided Acupuncture Imagery Treatment (VGAIT)
Treatment groups
20 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov